Video
Dr. O’Malley on the gender disparities among NCCN-cited trials for urothelial carcinoma
Author(s):
“These findings are an internal validation that the disparities we're seeing are real,” says Padraic O’Malley, MD, MSc, FRCSC.
Video Player is loading.
In this video, Padraic O’Malley, MD, MSc, FRCSC, discusses the background and findings of the study, “Gender disparities in the clinical trials and real-world utilization of systemic therapy in the management of urothelial carcinoma,” which was presented recently at the Society of Women in Urology Annual Clinical Mentoring Conference. O’Malley is an assistant professor in the department of urology at the University of Florida in Gainesville.
Related Videos
Matthew Galsky, MD, reacts to NIAGARA results, durvalumab approval for MIBC
Rana McKay, MD, on persistence and adherence to relugolix for prostate cancer
Timothy Lyon, MD, on recent change to outpatient complications metric in urology rankings
Neeraj Agarwal, MD, on talazoparib/enzalutamide efficacy by HRR gene mutation status
Jason Hafron, MD, considers the future for AI in urology
Sima Porten, MD, discusses the need to educate on the firefighter-bladder cancer link
Eugene Cone, MD, outlines potential impact of Expanded Access Program for rBCG
Investigators evaluate tamsulosin use in pediatric patients
Ruchika Talwar, MD, on how urologists can get involved in advocacy
Chad Ellimoottil, MD, on how urologists should approach telehealth in changing policy environment
Related Content
